Viewing StudyNCT00232999



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00232999
Status: COMPLETED
Last Update Posted: 2021-11-12
First Post: 2005-10-04

Brief Title: EfficacySafety Study of Nebulized IVX-0142 a Novel Antiallergic Drug in Mild Allergic Asthma
Sponsor: Teva Branded Pharmaceutical Products RD Inc
Organization: Teva Branded Pharmaceutical Products RD Inc

Conditions & Keywords Data

Conditions:
Name
Asthma
Keywords:
Name View
Bronchial hyperresponsiveness View
Allergic asthma View
Allergen challenge View